Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors $16.20 -0.46 (-2.76%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$17.17 +0.97 (+5.98%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock TLX vs. TEVA, SMMT, ITCI, GMAB, RDY, VTRS, MRNA, QGEN, ASND, and ROIVShould you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Moderna (MRNA), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Telix Pharmaceuticals Limited American Depositary Shares vs. Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris Moderna Qiagen Ascendis Pharma A/S Roivant Sciences Teva Pharmaceutical Industries (NYSE:TEVA) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership. Which has better valuation & earnings, TEVA or TLX? Telix Pharmaceuticals Limited American Depositary Shares has lower revenue, but higher earnings than Teva Pharmaceutical Industries. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.62B1.16-$1.64B-$1.15-14.73Telix Pharmaceuticals Limited American Depositary Shares$783.21M6.99N/AN/AN/A Does the MarketBeat Community believe in TEVA or TLX? Teva Pharmaceutical Industries received 1335 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.90% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133967.90% Underperform Votes63332.10% Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes4100.00% Underperform VotesNo Votes Does the media favor TEVA or TLX? In the previous week, Teva Pharmaceutical Industries had 24 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 24 mentions for Teva Pharmaceutical Industries and 0 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Teva Pharmaceutical Industries' average media sentiment score of 0.99 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.00 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media. Company Overall Sentiment Teva Pharmaceutical Industries Positive Telix Pharmaceuticals Limited American Depositary Shares Neutral Is TEVA or TLX more profitable? Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A Do insiders & institutionals believe in TEVA or TLX? 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate TEVA or TLX? Teva Pharmaceutical Industries presently has a consensus price target of $24.43, suggesting a potential upside of 44.21%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus price target of $22.00, suggesting a potential upside of 35.80%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryTeva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 12 of the 15 factors compared between the two stocks. Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLX vs. The Competition Export to ExcelMetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.47B$6.47B$5.33B$8.39BDividend YieldN/A2.64%5.21%4.10%P/E RatioN/A9.0626.7519.70Price / Sales6.99259.83392.41121.79Price / CashN/A65.8538.2534.62Price / BookN/A6.456.774.50Net IncomeN/A$143.98M$3.23B$248.22M7 Day Performance-2.88%0.38%0.43%-0.80%1 Month Performance-11.48%2.14%9.07%11.52%1 Year PerformanceN/A-0.33%18.59%8.99% Telix Pharmaceuticals Limited American Depositary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.20-2.8%$22.00+35.8%N/A$5.47B$783.21M0.00N/AGap DownTEVATeva Pharmaceutical Industries3.2803 of 5 stars$17.92+5.8%$24.43+36.4%+0.3%$20.31B$16.62B-12.3636,800Analyst UpgradeOptions VolumeSMMTSummit Therapeutics3.0102 of 5 stars$25.26+5.4%$37.40+48.1%+487.0%$18.76B$700,000.00-90.21110Positive NewsITCIIntra-Cellular Therapies0.8592 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560News CoverageGMABGenmab A/S3.4387 of 5 stars$19.93+2.9%$39.17+96.5%-29.5%$12.78B$21.64B11.451,660News CoveragePositive NewsHigh Trading VolumeRDYDr. Reddy's Laboratories2.3076 of 5 stars$13.93+3.9%$17.00+22.1%+2.5%$11.62B$311.31B22.1724,800Positive NewsGap UpVTRSViatris1.8923 of 5 stars$8.96+2.2%$10.50+17.2%-21.8%$10.63B$14.33B-12.1137,000Trending NewsMRNAModerna4.4457 of 5 stars$25.70+6.0%$53.95+109.9%-83.6%$9.94B$3.14B-2.773,900Trending NewsAnalyst ForecastQGENQiagen3.9764 of 5 stars$42.92+2.5%$48.42+12.8%+0.1%$9.54B$1.98B119.526,030Positive NewsASNDAscendis Pharma A/S3.376 of 5 stars$154.43+2.1%$216.07+39.9%+22.0%$9.42B$368.70M-21.75640Positive NewsROIVRoivant Sciences2.1115 of 5 stars$10.99+3.3%$17.50+59.2%-3.1%$7.84B$122.59M-73.26860Positive NewsUpcoming EarningsInsider Trade Related Companies and Tools Related Companies TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives VTRS Alternatives MRNA Alternatives QGEN Alternatives ASND Alternatives ROIV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLX Stock Free TLX Stock Alerts